Download this measure in English. BACK FACT-HN English Downloads Download PDF Download DOC

Download scoring documents for this measure. BACK NFSCI-19 Scoring Downloads Download DOC

NFHNSI-22 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Head & Neck Cancer Symptom Index - 22 Item Version For patients with Head & Neck cancer; a FACT/NCCN-Head & Neck Symptom Index LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview The NCCN/FACT Head & Neck Cancer Symptom Index-22 (NFHNSI-22) adequately reflects symptom and side effect concerns of advanced head & neck cancer patients as well as oncology physicians. Patients (N = 49) with advanced (Stages III and IV) head & neck cancers were recruited from participating National Comprehensive Cancer Network institutions and community cancer support organizations. Patients completed open-ended interviews and symptom checklists. Participating oncology physician experts also rated symptoms. Content validity was obtained by evaluating results alongside items in the FACIT system. Eleven oncologists categorized symptoms in terms of importance and whether the symptoms were primarily related to disease, treatment, or functional well-being. The NFHNSI-22 can be used to evaluate the most important disease-related symptoms, treatment side effects, and function/wellbeing in patients with advanced HCNs in clinical practice and research. MEASURE NAME: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Head & Neck Cancer Symptom Index - 22 Item Version (NFHNSI-22) VERSION: 2 NUMBER OF ITEMS: 22 PATIENT POPULATION: Head & neck cancer patients 18 years and older RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Disease-Related Symptoms – Physical, Disease-Related Symptoms – Emotional, Treatment Side Effects, Function/Well-Being TIME FOR COMPLETION: 5-10 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores and total scores possible. RELATED MEASURES: FACT-HN , FHNSI , FACT-G DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the NFHNSI-22 can be obtained by registering for permission. Users are not permitted to translate the NFHNSI-22 without permission from FACIT.org. Permission from FACIT.org to translate the NFHNSI-22 may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Cella, D., Paul, D., Yount, S., Winn, R., Chang, C-H, Banik, D., & Weeks, J. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Investigation 2003; 21(4): 526-535. doi: 10.108/CNV-120022366. Cella, D., Rosenbloom, S., Beaumont, J., Yount, J., Paul, D., Hampton, D., Abernethy, A., Jacobsen, P., Syrjala, K., & Von Roenn, J. Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer. Journal of the National Comprehensive Cancer Network; 2011; 9(3): 268-278. doi: 10.6004/jnccn.2011.0026. Pearman, T., Beaumont, J., Paul, D., Abernethy, A., Jacobsen, P., Syrjala, K., von Roenn, J., & Cella, D. Evaluation of treatment and disease-related symptoms in advanced head and neck cancer: validation of the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy-Head and Neck cancer symptom index (NFHNSI-22). Journal of Pain and Symptom Management 2013; 46(1): 113-120. doi: 10.1016/j.jpainsymman.2012.06.004. Rosenbloom, S., Yount, S., Yost, K., Hampton, D., Paul, D., Abernethy, A., Jacobsen, P., Syrjala, K., Von Roenn, J., Cella, D. Development and validation of eleven symptom indices to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands. Farquhar, I., Summers, K., Sorkin, A. (Eds.). The Value of Innovation: Impacts on Health, Life Quality and Regulatory Research. Emerald Group Publishing Inc. 2007; 16: 53-66. doi: 10.1016/S0194-3960(08)16003-6. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-HN Functional Assessment of Cancer Therapy – Head & Neck LEARN MORE FHNSI Functional Assessment of Cancer Therapy Head & Neck Cancer Symptom Index - 10 Item Version LEARN MORE FACT-G Functional Assessment of Cancer Therapy – General LEARN MORE

Over 25 years of methodologically rigorous COA translations. FACITtrans History OVER 25 YEARS OF METHODOLOGICALLY RIGOROUS COA TRANSLATIONS Today 2024 2023 2022 2021 ISO 2021 2020 ISO 2017 2016 2012 2009 2005 2004 1996 1994 Today 2024 Today Deep Scientific Roots and Cutting Edge Knowledge Quality and processes are our strength. Flexible, creative solutions are our calling card. As lead authors to the ISOQOL AI in COA translation guidance and numerous other publications , we are uniquely placed in the crossroads of technological advances and scientific rigor. While most of our work is for the pharmaceutical industry, we regularly partner with leading academic research groups including the Medical Social Services program at Northwestern University which was founded by our very own Dr. Cella. 2023 2024 Reinforcing Our Global Reach Vendor management expansion to meet demand and reinforce our global reach throughout Africa, India, LATAM, US, and Europe for translation, in-trial interviews and more. 2022 2023 Savic L., Arnold B., Baily A., Mackey DJ., Olaiya P. Translation and Linguistic Validation of the EXACT for Use with COPD Patients in African Countries. Presented at ISOQOL Calgary, October 2023. ISOQOL Poster of the Year In-trial interviews (qualitative, native-language interviews embedded in clinical trials) become a fixed part of our growing service offerings. Not only do we carry out the interviews, but we transcribe and translate them. Clients love our openness to new areas and our constant eye on quality and processes in any area we enter. 2022 In-Trial Research Services 2022 European Team Expansion to Meet Increased Demand 2021 2021 C-Path Selects FACITtrans as Their Preferred Translation Vendor 2021-2023 Thought Leadership in Action Our Executive Director, Emily Parks-Vernizzi, served as ISOQOL’s TCA-SIG Co-Chair and is currently a member of the TCA-SIG Steering Committee and the Digital Health and eCOA SIG ISO 2021 I SO 2021 FACITtrans Earns ISO 17100:2015 Certification Building off our ISO 9001:2015 certification, we placed our translation and processes under additional scrutiny to earn our ISO 17100:2015 certification, further reinforcing our commitment to the patients’ voice through our high-quality COA translation and linguistic validation process. We are proud to receive significant auditor praise for our processes at every surveillance and recertification audit. 2020 2020 JPRO Paper of the Year Our president, Benjamin Arnold, co-authors JPRO paper of the year, “Good practices for the translation, cultural adaptation, and linguistic validation of clinician-reported outcome, observer-reported outcome, and performance outcome measures”. FDA cites this article in their guidance to help clinical trial sponsors select, use, and optimize clinical outcome assessments (COAs) in their trials. McKown S, Acquadro C, Anfray C, Arnold B , Eremenco S, Giroudet C, Martin M, Weiss D. Good practices for the translation, cultural adaptation, and linguistic validation of clinician-reported outcome, observer-reported outcome, and performance outcome measures. J Patient Rep Outcomes 4 , 89 (2020). https://doi.org/10.1186/s41687-020-00248-z U.S. Food and Drug Administration. Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments; Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. FDA-2022-D-1385. U.S. Food and Drug Administration; October 2025. https://www.fda.gov/media/159500/download ISO 2017 I SO 2017 FACITtrans Earns ISO 9001:2015 Certification Quality processes have always been central to our work, which is why our group co-authored the 2005 ISPOR translations guidelines. Our ISO 9001:2015 certification in quality management underscores our commitment to our clients, research collaborators, and patients. 2016 2016-2018 Thought Leadership in Action Our President, Benjamin Arnold, served as ISOQOL’s Translation and Cross-Cultural Adaptation - Special Interest Group (TCA-SIG) Co-Chair, and is currently a member of the TCA-SIG Steering Committee. 2012 2012 eCOA Early Adapters The FACIT measurement system is a forerunner of eCOA adaptation/localization. FACIT Group establishes close ties with leading eCOA developers. 2009 2005 2009 FACITtrans is Born The translation and formatting team formerly part of The Center for Outcomes Research and Education (CORE) becomes FACITtrans, a boutique language service provider under the scientific direction of Dr. Cella, with close connections to the outcomes scientists at Northwestern’s Department of Medical Social Sciences. 2005 Industry Cornerstone Our translation group co-authors the landmark ISPOR translation and cultural adaptation guidelines that are now accepted as industry standard. Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A. and Erikson, P. (2005), Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value in Health, 8: 94-104. https://doi.org/10.1111/j.1524-4733.2005.04054.x 2004 2005 The Translation Group Publishes Universal Translation Article, Causes a Stir The translation group publishes the first-ever article to promote the universal approach to COA translation, which 20 years later is still considered methodologically novel. Eremenco S., Arnold B., Cella D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. 2004 Leading the Way with PROMIS FACITtrans develops first-ever PROMIS translations into Spanish and authors the definitive concept definitions for PROMIS. Arnold B., Correia H., Cella D. Translation of the Patient Reported Outcomes Measurement Information System into Spanish. Poster presentation at the 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, FL, 2009. 1996 1994 1996 The FACIT Translation Methodology Is Official Bonomi, A.E., Cella, D.F., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. 1994 Clinicians Request the FACT-G in Spanish Our translation group is born, with equivalence and quality at the forefront of our work. Meet the Team Benjamin Arnold, MA President Emily Parks-Vernizzi, MBA Executive Director MEET THE WHOLE TEAM FACITtrans is ISO 9001:2015 and ISO 17100:2015 certified.

Download this measure in English. BACK FKSI-10 English Downloads Download PDF Download DOC

View all available languages for this measure. BACK FACT-GOG-NTX-13 Languages Chinese - Simplified Chinese - Traditional Czech Danish Dutch English Finnish French German Greek Gujarati Hindi Hungarian Italian Japanese Korean Marathi Portuguese Russian Sesotho Setswana Spanish Swedish Turkish

FBrSI Functional Assessment of Cancer Therapy Brain Cancer Symptom Index - 15 Item Version For patients with Brain cancer; a FACT-Brain Symptom Index (a subset of FACT-Br containing 15 items) LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview Below are the details for the FBrSI measure: MEASURE NAME: Functional Assessment of Cancer Therapy Brain Cancer Symptom Index - 15 Item Version (FBrSI) VERSION: 4 NUMBER OF ITEMS: 15 PATIENT POPULATION: Brain cancer patients 18 years and older RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Brain Cancer Subscale TIME FOR COMPLETION: Less than 5 minutes SCORING: Manual scoring template, some items are reverse scored. Total scores available. SAS/SPSS algorithms available RELATED MEASURES: FACT-Br , NFBrSI-24 , FACT-G DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FBrSI can be obtained by registering for permission. Users are not permitted to translate the FBrSI without permission from FACIT.org. Permission from FACIT.org to translate the FBrSI may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Cella, D., Paul, D., Yount, S., Winn, R., Chang, C-H, Banik, D., & Weeks, J. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Investigation 2003; 21(4): 526-535. doi: 10.108/CNV-120022366. Cella, D., Rosenbloom, S., Beaumont, J., Yount, J., Paul, D., Hampton, D., Abernethy, A., Jacobsen, P., Syrjala, K., & Von Roenn, J. Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer. Journal of the National Comprehensive Cancer Network; 2011; 9(3): 268-278. doi: 10.6004/jnccn.2011.0026. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-Br Functional Assessment of Cancer Therapy – Brain LEARN MORE NFBrSI-24 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Brain Cancer Symptom Index - 24 Item Version LEARN MORE FACT-G Functional Assessment of Cancer Therapy – General LEARN MORE

View all available languages for this measure. BACK FKSI-23 Languages English Spanish Turkish

Download this measure in English. BACK FOSI English Downloads Download PDF Download DOC

FACIT-Pal Functional Assessment of Chronic Illness Therapy - Palliative Care LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview Below are the details for the FACIT-Pal measure: MEASURE NAME: Functional Assessment of Chronic Illness Therapy - Palliative Care (FACIT-Pal) VERSION: 4 NUMBER OF ITEMS: 39 PATIENT POPULATION: Palliative care patients RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Palliative Care Subscale TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores and total scores possible. SAS/SPSS algorithms available. RELATED MEASURES: FACIT-Pal-14 , FACIT-Sp , FACIT-Sp-EX DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACIT-Pal can be obtained by registering for permission. Users are not permitted to translate the FACIT-Pal without permission from FACIT.org. Permission from FACIT.org to translate the FACIT-Pal may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Bagcivan G., Bredle J., Bakitas M., Guciz Dogan B. Reliability and Validity of the Turkish Version of the FACIT-PAL Quality of Life Instrument. J Pain Symptom Manage . 2019 Aug; 58(2): 297-305.e4. doi: 10.1016/j.jpainsymman.2019.04.020. Epub 2019 May 13. PMID: 31096004. Bakitas, M., Lyons, K., Hegel, M., Balan, S., Barnett, K., Brokaw, F., Byock, I., Hull, J., Li, Z., McKinstry, E., Seville, J., & Ahles, T. The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: Baseline findings, methodological challenges, and solutions. Palliative and Supportive Care 2009; 7: 75–86. doi: 10.1017/S1478951509000108. Frazer MS, Mobley P. A mixed methods analysis of quality of life among late-life patients diagnosed with chronic illnesses. Health Qual Life Outcomes 2017;15:222. doi:10.1186/s12955-017-0797-3 Greisinger, A., Lorimor, R., Aday, L., Winn, R., & Baile, W. Terminally III Cancer Patients: Their most important concerns. Cancer Practice 1997; 5(3): 147-154. King, M., Agar, M., Currow, D., Hardy, J., Fazekas, B., & McCaffre, N. Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7). Supportive Care in Cancer 2020; 28:141–153. doi: 10.1007/s00520-019-04754-9. Lyons,K., Bakitas, M., Hegel, M., Hanscom, B, Hull, J., & Ahles, T. Reliability and Validity of the Functional Assessment of Chronic Illness Therapy- Palliative Care (FACIT-Pal) Scale. Journal of Pain and Symptom Management 2009; 37(1). doi: 10.1016/j.jpainsymman.2007.12.015. Moldón-Ballesteros E, Llamas-Ramos I, Calvo-Arenillas JI, Cusi-Idigoras O, Llamas-Ramos R. Validation of the Spanish Versions of FACIT-PAL and FACIT-PAL-14 in Palliative Patients. Int J Environ Res Public Health 2022;19:10731. doi:10.3390/ijerph191710731. Siegert R, Selman L, Higginson IJ, et al. A psychometric evaluation of the functional assessment of chronic illness therapy-palliative care (FACIT-Pal) scale with palliative care samples in three African countries. J Pain Symptom Manage 2014;48:983-991. doi:10.1016/j.jpainsymman.2014.01.010. Zeng, L., Bedard, G., Cella, D., Thavarajah, N., Chen, E., Zhang, L., Bennett, M., Peckham, K., DeCosta, S., Beaumont, J., Tsao, M., Danjoux, C., Barnes, E., Sahgal, & A. Chow, E. (2013) Preliminary results of the generation of a shortened quality of life assessment for patients with advanced cancer: the FACIT-Pal-14. Journal of Palliative Medicine 2013; 16(5): 509-515. doi: 10.1089/jpm.2012.059. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACIT-Pal-14 Functional Assessment of Chronic Illness Therapy - Palliative Care 14 Item Version LEARN MORE FACIT-Sp Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being LEARN MORE FACIT-Sp-EX Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being Expanded Version LEARN MORE

FAIT-F Functional Assessment of Incontinence Therapy – Fecal LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview Below are the details for the FAIT-F measure: MEASURE NAME: Functional Assessment of Incontinence Therapy – Fecal (FAIT-F) VERSION: 4 NUMBER OF ITEMS: 39 PATIENT POPULATION: Patients 18 and older with fecal incontinence RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Fecal Incontinence Subscale TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores and total scores available. SAS/SPSS algorithms available. RELATED MEASURES: FAIT-U , FACIT-D , FACIT-AD DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FAIT-F can be obtained by registering for permission. Users are not permitted to translate the FAIT-F without permission from FACIT.org. Permission from FACIT.org to translate the FAIT-F may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FAIT-U Functional Assessment of Incontinence Therapy – Urinary LEARN MORE FACIT-D Functional Assessment of Chronic Illness Therapy – Diarrhea LEARN MORE FACIT-AD Functional Assessment of Chronic Illness Therapy - Abdominal Discomfort LEARN MORE

View all available languages for this measure. BACK FACIT-Pal Languages Bengali Burmese Chinese – Simplified Dutch English Farsi German Greek Hindi Indonesian Japanese Malay Malayalam Portuguese Sinhala Spanish Swahili Tagalog Tamil Telugu Thai Turkish Vietnamese